A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/257
A61K 31/205 (2006.01) A61K 31/22 (2006.01) A61K 31/23 (2006.01) A61M 1/16 (2006.01)
Patent
CA 1134274
"Use of acyl-carnitines in a therapeutical method for treating chronic uraemic patients undergoing regular dialysis and liquid composition for use therein" Abstract of the disclosure A therapeutical method for treating uraemic patients in regular dialysis treatment (RDT) is disclosed, wherein an acyl- carnitine (tipically acetyl-carnitine) is administered to the patients. The acyl-carnitine can be administered over the whole treatment period by the oral route exclusively. Alternatively, whilst oral administration is carried out in those days in which the patient is not subjected to the haemodialytic session, when the patient undergoes dialysis, the acyl-carnitine is administere by slow infusion, or an acyl-carnitine-containing dialyzing liquid is used. Furthermore, a suitable dialyzing solution is also disclosed.
327599
Cavazza Claudio
Robic Robic & Associes/associates
LandOfFree
Use of acyl-carnitines in a therapeutical method for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of acyl-carnitines in a therapeutical method for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of acyl-carnitines in a therapeutical method for... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-165706